Antimicrobial resistance (AMR) is defined as the ability of a microorganism to resist the action of one or more antimicrobial agents or antibiotics. Misuse and abuse of antibiotics worldwide has eroded their efficacy and antibiotic-resistant bacteria are rapidly spreading across the globe. Due to the complexity of the problem, its cross-border character and the high societal cost of antimicrobial resistance, it has become a global public health concern that requires urgent and coordinated action across sectors. Infection prevention measures, control programmes and diagnostic technologies all play a key role in tackling antimicrobial resistance.
HFE believes that a multi-level, multi-sector, and collaborative approach is necessary to effectively tackle such a public health emergency.
Therefore, we are part of:
EU Joint Action on AMR and Healthcare-Associated Infections (EU-JAMRAI) which brings together 44 partners from 28 countries and more than 30 stakeholders. EU-JAMRAI mission is fostering synergies among EU member States developing and implementing effective One Health policies to fight the rising threat of AMR and reduce HAI. Visit the website here.
AMR Stakeholder Network brings together 80 leading organisations and individuals committed to tackling Antimicrobial Resistance (AMR) at national, regional and European level, covering all dimensions of the ‘One Health’ approach. Together we call for immediate action and commitment from EU and national policy-makers to tackle the AMR public health crisis. Visit the website here.